ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,376,000 | +39.9% | 1,143,790 | 0.0% | 0.51% | +64.8% |
| Q4 2020 | $28,869,000 | -33.1% | 1,143,790 | 0.0% | 0.31% | -50.8% |
| Q3 2020 | $43,132,000 | -34.8% | 1,143,790 | -25.9% | 0.63% | -41.2% |
| Q2 2020 | $66,105,000 | +120.3% | 1,543,790 | 0.0% | 1.07% | +37.0% |
| Q1 2020 | $30,011,000 | -25.2% | 1,543,790 | 0.0% | 0.78% | -1.9% |
| Q4 2019 | $40,107,000 | -4.7% | 1,543,790 | 0.0% | 0.80% | -29.7% |
| Q3 2019 | $42,075,000 | +1.5% | 1,543,790 | 0.0% | 1.13% | +19.2% |
| Q2 2019 | $41,450,000 | -7.1% | 1,543,790 | 0.0% | 0.95% | -24.5% |
| Q1 2019 | $44,630,000 | +7.4% | 1,543,790 | 0.0% | 1.26% | -20.4% |
| Q4 2018 | $41,574,000 | – | 1,543,790 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |